(Q38307449)

2 September 2017

1 reference

title

GLP-1: a mediator of the beneficial metabolic effects of bariatric surgery? (English)

1 reference

2 September 2017

0 references

3

Rachel L Batterham

1 reference

2 September 2017

Sean Manning

1

1 reference

2 September 2017

Andrea Pucci

series ordinal

2

1 reference

2 September 2017

publication date

1 January 2015

1 reference

2 September 2017

1 reference

2 September 2017

volume

30

1 reference

2 September 2017

issue

1

1 reference

2 September 2017

page(s)

50-62

1 reference

Preoperative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Acute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Recent advances in clinical practice challenges and opportunities in the management of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Incretin dysfunction in type 2 diabetes: clinical impact and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Gastric bypass surgery, but not caloric restriction, decreases dipeptidyl peptidase-4 activity in obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Mechanisms behind the immediate effects of Roux-en-Y gastric bypass surgery on type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Cognitive function after bariatric surgery: evidence for improvement 3 years after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Alterations in gastrointestinal, endocrine, and metabolic processes after bariatric Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Gastric bypass and banding equally improve insulin sensitivity and β cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Effects of proximal gut bypass on glucose tolerance and insulin sensitivity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Metabolic/bariatric surgery worldwide 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

The comparative effectiveness of sleeve gastrectomy, gastric bypass, and adjustable gastric banding procedures for the treatment of morbid obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Peripheral activation of the Y2-receptor promotes secretion of GLP-1 and improves glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Glucagon-like peptide-1: glucose homeostasis and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Gastric bypass and nesidioblastosis--too much of a good thing for islets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

GLP-1 response to a mixed meal: what happens 10 years after Roux-en-Y gastric bypass (RYGB)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Immunoassays for the incretin hormones GIP and GLP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Discovery and optimisation of 1-hydroxyimino-3,3-diphenylpropanes, a new class of orally active GPBAR1 (TGR5) agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Postprandial diabetic glucose tolerance is normalized by gastric bypass feeding as opposed to gastric feeding and is associated with exaggerated GLP-1 secretion: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

The role of gut hormones in glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Limited recovery of β-cell function after gastric bypass despite clinical diabetes remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Gastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

GLP-1 and peptide YY secretory response after fat load is impaired by insulin resistance, impaired fasting glucose and type 2 diabetes in morbidly obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

The gut endocrine system as a coordinator of postprandial nutrient homoeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

GLP-1R responsiveness predicts individual gastric bypass efficacy on glucose tolerance in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Comparison of metabolic effects of surgical-induced massive weight loss in patients with long-term remission versus non-remission of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

The effects of weight loss strategies on gastric emptying and appetite control

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

The regulation of food intake by the gut-brain axis: implications for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and β-cell Function in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Effects of gastric bypass surgery on glucose absorption and metabolism during a mixed meal in glucose-tolerant individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

The WNT signalling pathway and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Eating behavior and glucagon-like peptide-1-producing cells in interposed ileum and pancreatic islets in rats subjected to ileal interposition associated with sleeve gastrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Evidence for paracrine/autocrine regulation of GLP-1-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Rise of oxyntomodulin in response to oral glucose after gastric bypass surgery in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Adipose inflammation in obesity: relationship with circulating levels of inflammatory markers and association with surgery-induced weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Effects of ingestion routes on hormonal and metabolic profiles in gastric-bypassed humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Rapid improvement in diabetes after gastric bypass surgery: is it the diet or surgery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Preproglucagon neurons project widely to autonomic control areas in the mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Incretin-based therapies for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Ileal brake: a sensible food target for appetite control. A review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

The role of gut hormone peptide YY in energy and glucose homeostasis: twelve years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Pharmacotherapy for obesity: novel agents and paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Roux-en-Y gastric bypass in rats increases sucrose taste-related motivated behavior independent of pharmacological GLP-1-receptor modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

GLP-1 responses are heritable and blunted in acquired obesity with high liver fat and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Mechanisms underlying the rapid degradation and elimination of the incretin hormones GLP-1 and GIP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Bariatric surgery versus conventional medical therapy for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Gut peptides in the regulation of food intake and energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Removal of duodenum elicits GLP-1 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Vertical sleeve gastrectomy reduces hepatic steatosis while increasing serum bile acids in a weight-loss-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Reduced food intake after jejunoileal bypass: a possible association with prolonged gastric emptying and altered gut hormone patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Chronic exposure to GLP-1 increases GLP-1 synthesis and release in a pancreatic alpha cell line (α-TC1): evidence of a direct effect of GLP-1 on pancreatic alpha cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Characterisation of oral and i.v. glucose handling in truncally vagotomised subjects with pyloroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Is Type II Diabetes Mellitus (NIDDM) a Surgical Disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Effect of bypassing the proximal gut on gut hormones involved with glycemic control and weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

The impact of bariatric surgery on nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Effect of Roux-en-Y gastric bypass vs sleeve gastrectomy on glucose and gut hormones: a prospective randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Ileal transposition surgery produces ileal length-dependent changes in food intake, body weight, gut hormones and glucose metabolism in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Emerging combinatorial hormone therapies for the treatment of obesity and T2DM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Bariatric surgery and psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Altered islet function and insulin clearance cause hyperinsulinemia in gastric bypass patients with symptoms of postprandial hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Ghrelin suppression is associated with weight loss and insulin action following gastric bypass surgery at 12 months in obese adults with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Potential of incretin-based therapies for non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

The physiological role of GLP-1 in human: incretin, ileal brake or more?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Lessons learned from gastric bypass operations in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Bariatric surgery and long-term cardiovascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Gut and pancreatic hormones after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Could the mechanisms of bariatric surgery hold the key for novel therapies? report from a Pennington Scientific Symposium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Enhanced Intestinal Motility during Oral Glucose Tolerance Test after Laparoscopic Sleeve Gastrectomy: Preliminary Results Using Cine Magnetic Resonance Imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

A role for glucagon-like peptide-1 in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Cardiovascular biology of the incretin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Effects of sleeve gastrectomy and medical treatment for obesity on glucagon-like peptide 1 levels and glucose homeostasis in non-diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Magnitude and variability of the glucagon-like peptide-1 response in patients with type 2 diabetes up to 2 years following gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

β-cell function after weight-loss induced by bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Enhanced thermic effect of food after Roux-en-Y gastric bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like Peptide 1 receptor deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Lower glycemic fluctuations early after bariatric surgery partially explained by caloric restriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Reduction in obesity-related comorbidities: is gastric bypass better than sleeve gastrectomy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Soci

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00027.2014

10.1152/PHYSIOL.00027.2014

21 January 2018

Identifiers

DOI

1 reference

release_37igawoqqfdfbdtcyyev3yoqoy

2 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/37igawoqqfdfbdtcyyev3yoqoy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference